Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease - Wikidata - awgldk - TriplyDB

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

http://www.wikidata.org/entity/Q36778227

about

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study Aquaporin-4 autoimmunity B Cells and Autoantibodies in Multiple Sclerosis Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus.Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.MOG antibody-associated diseases Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children Demographic and clinical features of neuromyelitis optica: A review.B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.Autoimmunity: The good, the bad, and the ugly Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.Astrocyte barriers to neurotoxic inflammation.Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?Experimental models of neuromyelitis optica: current status, challenges and future directions.Atypical Optic Neuritis.MOG antibody-related disorders: common features and uncommon presentations.Therapeutic options in neuromyelitis optica spectrum disorders.Investigation-Directed Approach to Inflammatory Optic Neuropathies.Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients.Clinical manifestations of neuromyelitis optica in male and female patients.T cells targeting neuromyelitis optica autoantigen aquaporin-4 cause paralysis and visual system injury.Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica.The Gut Microbiome in Neuromyelitis Optica.

P2860

Q21146662-A5B1EFEC-A62D-4F40-BA44-4BC94861D115 Q21558554-1EE2DFF3-7803-4CA6-92BB-B3D0E82AC41E Q26799559-D8AEE238-26A0-4350-AEE7-CDF3BCE6189C Q26801386-D63228A3-5375-407F-8105-9ABA3795B091 Q28256650-765B4056-ABF7-4206-864E-D943BD129F4F Q28270042-3F47C553-80C0-4315-BC04-BB2DC3FB4B04 Q29036090-6704148F-F504-4581-BD0D-DE734853CF93 Q30371412-2604EE7C-FC2D-4E27-8245-F8F5F851B488 Q33645795-82933AD2-D2D6-4D64-8B23-C828FBA8D3BE Q33697662-F14C5E64-9C44-48F3-9180-182DD2EFAEAD Q34486841-590AEA86-0D24-4408-8383-C2FDF54601BC Q35023345-9DDC44BE-CFD5-48E0-B721-2F255C624AF2 Q35179839-AAACD2DA-3684-4103-A0E0-82F3CD18C621 Q35718428-F567A654-5CAF-41FE-A549-58F8A046EDF6 Q35937581-B720784A-B1E9-4893-A976-7592B407F9EA Q36261569-D59CCC3B-AEE0-4B5B-8DB8-B76A29A7AAF4 Q36359919-672DF59F-0C9B-459E-80A9-1043D287B9DA Q36511714-BF9DABA3-8385-45EE-8747-284E333DE751 Q36827205-6E640EFF-7010-4B86-9033-DD1F73BD44AC Q37197191-AF237DF3-5FF7-4D71-8427-0B5785E53538 Q37374434-AC87B4B4-95C8-460B-8AF1-1A1D426FC3DE Q37383474-8A23B804-3B5F-4773-813B-08035C822214 Q37597818-54BB6428-0551-4557-9525-28E53DBB0632 Q38337465-DEED25F7-A6FF-443B-B526-861362862605 Q38537409-25F92610-ADDC-457B-A92B-2CAEAD0BAC90 Q38607165-78D58ED9-024A-414E-8216-5D15A6FE221F Q38645211-6A965FBA-81D2-4AD4-9C5D-C3CEDBB6F23B Q38721559-CAAAAD1B-F970-4C4E-9E0B-97C99219F338 Q38766838-147351DF-B85A-4014-AEF7-84BA97DEF888 Q38853499-9E918266-DB0A-4FAA-8341-6D914F172E1D Q38984981-80B3F7C0-6EA3-407D-8829-43A74503711C Q40079955-3B868F14-DB34-46F1-8317-BE0E86BA8CB7 Q40694035-D2F2EE6C-7793-4779-A744-A5FEAFD847C4 Q41098721-829AEC04-DCC0-438D-B355-471CD8A8E2E4 Q41106804-CF0B6A0B-745C-4D87-ABE8-50DD436EBF5B Q41877972-CC90323C-543A-4CD1-AA86-CC9CA8CA8786 Q42844764-BC5CAA37-6936-4703-A4AF-09C7266D823E Q44875571-6B22166A-3704-4DA4-83A8-515986F7BED5 Q47192132-CFA9B56A-CBDC-4282-B402-E7C0C8C180F8 Q47252742-33A6EA53-DAFF-41FF-9C4D-2D907C3EEB69

P2860

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

http://www.wikidata.org/entity/Q36778227

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Antibodies to MOG and AQP4 in ...... d limited forms of the disease

@ast

Antibodies to MOG and AQP4 in ...... d limited forms of the disease

@en

type

label

Antibodies to MOG and AQP4 in ...... d limited forms of the disease

@ast

Antibodies to MOG and AQP4 in ...... d limited forms of the disease

@en

prefLabel

Antibodies to MOG and AQP4 in ...... d limited forms of the disease

@ast

Antibodies to MOG and AQP4 in ...... d limited forms of the disease

@en

P1433

Q36778227-3ADCC175-5BF9-43BD-A641-6C613417BA3D

P1476

Q36778227-EA3B738F-8214-4389-BF72-978EF9078E75

P2093

Q36778227-0DA49F13-1D88-490A-A1D2-6F8903A25936

Q36778227-12F6705C-8220-4CFC-BD79-13E454B269C1

Q36778227-1AB5E8F9-B98C-4A37-A3D1-687BA8B0D565

Q36778227-3CA94CA7-AEA3-49E5-9FC7-D17326740D76

Q36778227-62F2C022-ABD2-4896-B893-E89116E3D46C

Q36778227-6DE05CCF-1A27-4550-B8EE-A3063799E6B8

Q36778227-7862083F-0546-4D9A-9F83-2A1396C7397B

Q36778227-79641C84-C452-4C26-B412-FCF2BEE230B0

Q36778227-8BBE0B6B-B31D-4F31-9DAE-8271C779BC00

Q36778227-B12926BA-1C43-47F2-BB23-3B5E95DA7946

P2860

Q36778227-00FC9F29-A4B1-4729-A1B9-967F133447A1

Q36778227-01D06E00-3135-43AB-AD5F-51287A7B34F1

Q36778227-274422E2-F9FA-4CC6-9FF8-E017D3492CAE

Q36778227-28073697-C28D-4933-BE93-60F37FA688F3

Q36778227-2DA19B6B-5A2C-4342-AC1F-EB50ECEF1D10

Q36778227-3C350FB0-2E56-4901-9380-1A295F786505

Q36778227-472D3683-7A3E-486C-8582-15C541042628

Q36778227-4C49E39B-1E10-4964-9893-9EC63FA78B44

Q36778227-55F3DAD9-FDDE-4A8D-8732-9E2D39FF26C4

Q36778227-5D3434A0-CF0A-48A0-8610-B1B220710580

P304

Q36778227-32B6A477-991D-4112-AC4E-3A5A1CEFEAB9

P31

Q36778227-FC521159-A347-44F8-9C26-BFB36FAA953E

P356

Q36778227-039FDBAB-8DFC-41BE-BDF3-E0C0A2B0EE6E

P433

Q36778227-8769D7A7-CD0C-4FD7-9204-8CA908661B8B

P478

Q36778227-8724F0C7-34B0-4895-970D-E855F775CECF

P50

Q36778227-47B24989-9834-4D9D-A00E-DC02CA0B2B00

Q36778227-8789B0F9-B566-4B1C-9ED6-2EBB2FEFBB7D

Q36778227-CD1CC060-8D66-4960-8E91-4C79618A2F7C

Q36778227-FF5B0EFF-717E-4B28-BE62-B64FB2C2EEB7

P577

Q36778227-86785E25-1FCB-4CD7-B939-23C8AE2DA413

P5875

Q36778227-3B556E6E-EF77-4CB4-B810-6C445ED00623

P698

Q36778227-84ECB8A4-B972-4E8C-AE58-9B1CB88E4667

P921

Q36778227-FCCD1717-CF60-495B-B547-598E15512F97

P932

Q36778227-9B56279B-9172-4A1E-8E99-BDC4E4207521

P356

1352458514555785

P1433

Multiple Sclerosis Journal

P1476

Antibodies to MOG and AQP4 in ...... d limited forms of the disease

@en

P2093

Albert Saiz

http://www.w3.org/2001/XMLSchema#string

Alvaro Cobo Calvo

http://www.w3.org/2001/XMLSchema#string

Bonaventura Casanova

http://www.w3.org/2001/XMLSchema#string

Francesc Graus

http://www.w3.org/2001/XMLSchema#string

Javier Olascoaga

http://www.w3.org/2001/XMLSchema#string

Julián Benito-León

http://www.w3.org/2001/XMLSchema#string

Kevin Rostásy

http://www.w3.org/2001/XMLSchema#string

Lidia Sabater

http://www.w3.org/2001/XMLSchema#string

Lluís Ramió-Torrentà

http://www.w3.org/2001/XMLSchema#string

María Sepulveda

http://www.w3.org/2001/XMLSchema#string

P2860

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

The spectrum of MOG autoantibody-associated demyelinating diseases

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

The clinical course of neuromyelitis optica (Devic's syndrome).

The spectrum of neuromyelitis optica.

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Revised diagnostic criteria for neuromyelitis optica.

An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays

P304

866-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458514555785

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Georgina Arrambide

Thaís Armangue

P577

2014-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267631185

http://www.w3.org/2001/XMLSchema#string

P698

25344373

http://www.w3.org/2001/XMLSchema#string

P921

P932

4824843

http://www.w3.org/2001/XMLSchema#string